Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies
Xenofon Baraliakos, Atul A. Deodhar, Désirée M F M van der Heijde, Marina Magrey, Walter P. Maksymowych, Tetsuya Tomita and 8 more
- Rank
- 48 of 1,011
- Percentile
- top 4.8%
- Where
- Annals of the Rheumatic Diseases, 2023
- Citations
- 58
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.